Androgen Axis Suppression

1

Review clinical trials related to Androgen Axis Suppression. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

PROSTATE-IQ: Parallel RandOmized STudy of Personalized Apalutamide Treatment and Evaluation to Improve Quality of Life in Post-Operative Radiation With Androgen Axis Suppression. A Phase III Multi-center Study for Men With Detectable PSA After Prostatectomy for Prostate Cancer.

1. Personalize treatment for prostate cancer based on how aggressive the disease is and 2. Learn if apalutamide-based treatment can help to reduce fatigue and other side effects of treatment in participants who are being treated with radiation therapy for prostate cancer, as compared to standard therapy.

Participants needed: 120
Trial details
Phase: Phase 3Age: 18+Biological sex: MaleType: InterventionalSponsor: M.D. Anderson Cancer CenterUpdated: Jun 26, 2026Locations: 5
Eligibility criteria

Histologically confirmed prostate cancer. [+8]

Use of post-prostatectomy testosterone suppression prior to registration (use of... [+9]